# Ocular Therapeutix (OCUL) — Overview

OCUL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ocul

## Price

Last close $7.38 on Oct 15, 2026. 52-week range $6.88 – $16.11.

## Company profile

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $52.1M |
| Revenue (quarter) | $13.5M |
| Revenue growth (year over year) | 0.12% |
| Gross profit (trailing twelve months) | $45.3M |
| Gross margin | 87.11% |
| Net income (trailing twelve months) | −$301.4M |
| Net income (quarter) | −$78.8M |
| Net income growth (year over year) | -16.15% |
| Net margin | -579.09% |
| Return on equity | -72.99% |
| EPS (trailing twelve months) | −$1.40 |
| Book value per share | $2.37 |
| P/E (trailing twelve months) | — |
| Price to book | 3.1 |
| Debt to assets | 22.53% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Ocular Therapeutix (OCUL) profitable?

No. Ocular Therapeutix reported a net loss of $301.4M over the trailing twelve months.

### How much revenue does Ocular Therapeutix (OCUL) make?

Ocular Therapeutix generated $52.1M in revenue over the trailing twelve months, up 0.12% year over year.

### How do I buy stock in Ocular Therapeutix (OCUL)?

OCUL trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).